160,99 €
Reflecting the progress in recent years, this book provides in-depth information on the preparation, chemistry, and engineering of bioceramic coatings for medical implants. It is authored by two renowned experts with over 30 years of experience in industry and academia, who know the potentials and pitfalls of the techniques concerned.
Following an introduction to the principles of biocompatibility, they present the structures and properties of various bioceramics from alumina to zirconia. The main part of the work focuses on coating technologies, such as chemical vapor deposition, sol-gel deposition and thermal spraying. There then follows a discussion of the major interactions of bioceramics with bone or tissue cells, complemented by an overview of the in-vitro testing methods of the biomineralization properties of bioceramics. The text is rounded off by chapters on the functionalization of bioceramic coatings and a look at future trends.
As a result, the authors bring together all aspects of the latest techniques for designing, depositing, testing, and implementing improved and novel bioceramic coating compositions, providing a full yet concise overview for beginners and professionals.
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 983
Veröffentlichungsjahr: 2015
Cover
Related Titles
Title Page
Copyright
Preface
References
Glossary
Chapter 1: Bioceramics – A Historical Perspective
Synopsis
1.1 Alumina
1.2 Zirconia
1.3 Calcium Phosphates
References
Chapter 2: Socio-Economic Aspects and Scope of Bioceramic Materials and Biomedical Implants
Synopsis
2.1 Types of Biomaterial
2.2 The Growing Global and Regional Markets for Biomedical Implants
2.3 Role of Bioceramic Coatings in Arthroplasty
2.4 Ceramic Femoral Ball Heads
References
Chapter 3: Fundamentals of Interaction of Bioceramics and Living Matter
Synopsis
3.1 Principle of Biocompatibility
3.2 Hierarchical Structure of Bone and Teeth
3.3 Bioceramic/Bone Interface
3.4 Basic Aspects of Biomineralisation
3.5 Interaction at a Cellular Level
3.6 Interaction at a Tissue Level
3.7 Advantages of Hydroxyapatite and Bioglass Coatings
3.8 The Promise of Cytokines
References
Chapter 4: Structure and Properties of Bioceramics Used in Orthopaedic and Dental Implants
Synopsis
4.1 Bioinert Ceramics
4.2 Bioactive Ceramics
References
Chapter 5: Technology of Coating Deposition
Synopsis
5.1 Overview
5.2 Non-Thermal Deposition Methods
5.3 Thermal Deposition Methods
5.4 Other Techniques
References
Chapter 6: Deposition, Structure, Properties and Biological Function of Plasma-Sprayed Bioceramic Coatings
Synopsis
6.1 General Requirements and Performance Profile of Plasma-Sprayed Bioceramic Coatings
6.2 Structure and Biomedical Functions of Bioceramic Coatings
6.3 The Role of Bond Coats
References
Chapter 7: Characterisation and Testing of Bioceramic Coatings
Synopsis
7.1 Phase Composition: X-ray Diffraction
7.2 Phase Composition: Vibrational (Infrared and Raman) Spectroscopy
7.3 Phase Composition: Nuclear Magnetic Resonance Spectroscopy
7.4 Phase Composition: Cathodoluminescence
7.5 Adhesion of Coatings to the Substrate
7.6 Residual Coating Stresses
7.7 Fundamentals of Roughness and Porosity
7.8 Microhardness
7.9 Potentiodynamic Polarisation and Electrochemical Impedance Spectroscopy (EIS)
7.10 Biological Performance Testing of Bioceramic Coatings
References
Chapter 8: Future Developments and Outlook
Synopsis
References
Appendix Relevant Scientific Journals/Book Series with Bioceramic Content
Index
End User License Agreement
xi
xii
xiii
xiv
xv
xvii
xviii
xix
xx
xxi
xxii
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
73
71
72
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
445
446
447
448
449
450
451
452
453
455
456
457
459
460
461
462
463
464
465
466
467
Cover
Table of Contents
Preface
Begin Reading
Figure 1.1
Figure 2.1
Figure 2.2
Figure 2.3
Figure 2.4
Figure 2.5
Figure 2.6
Figure 2.7
Figure 2.8
Figure 2.9
Figure 2.10
Figure 2.11
Figure 3.1
Figure 3.2
Figure 3.3
Figure 3.4
Figure 3.5
Figure 3.6
Figure 3.7
Figure 3.8
Figure 3.9
Figure 3.10
Figure 4.1
Figure 4.2
Figure 4.3
Figure 4.4
Figure 4.5
Figure 4.6
Figure 4.7
Figure 4.8
Figure 4.9
Figure 4.10
Figure 4.11
Figure 4.12
Figure 4.13
Figure 4.14
Figure 4.15
Figure 4.16
Figure 4.17
Figure 4.18
Figure 4.19
Figure 4.20
Figure 4.21
Figure 4.22
Figure 4.23
Figure 4.24
Figure 5.1
Figure 5.2
Figure 5.3
Figure 5.4
Figure 5.5
Figure 5.6
Figure 5.7
Figure 5.8
Figure 5.9
Figure 5.10
Figure 5.11
Figure 5.12
Figure 5.13
Figure 5.14
Figure 5.15
Figure 5.16
Figure 5.17
Figure 5.18
Figure 5.19
Figure 5.20
Figure 5.21
Figure 5.22
Figure 5.23
Figure 5.24
Figure 5.25
Figure 5.26
Figure 5.27
Figure 5.28
Figure 5.29
Figure 5.30
Figure 5.31
Figure 5.32
Figure 5.33
Figure 5.34
Figure 5.35
Figure 5.36
Figure 5.37
Figure 5.38
Figure 5.39
Figure 5.40
Figure 5.41
Figure 5.42
Figure 5.43
Figure 5.44
Figure 5.45
Figure 5.46
Figure 5.47
Figure 5.48
Figure 5.49
Figure 5.50
Figure 6.1
Figure 6.2
Figure 6.3
Figure 6.4
Figure 6.5
Figure 6.6
Figure 6.7
Figure 6.8
Figure 6.9
Figure 6.10
Figure 6.12
Figure 6.11
Figure 6.13
Figure 6.14
Figure 6.15
Figure 6.16
Figure 6.17
Figure 6.18
Figure 6.20
Figure 6.21
Figure 6.22
Figure 6.23
Figure 6.24
Figure 7.1
Figure 7.2
Figure 7.3
Figure 7.4
Figure 7.5
Figure 7.6
Figure 7.7
Figure 7.9
Figure 7.8
Figure 7.10
Figure 7.11
Figure 7.12
Figure 7.13
Figure 7.15
Figure 7.16
Figure 7.17
Figure 7.18
Figure 7.19
Figure 7.20
Figure 7.21
Figure 7.22
Figure 7.23
Figure 7.24
Figure 7.25
Figure 7.26
Figure 7.27
Figure 7.28
Figure 7.29
Figure 7.30
Figure 7.31
Figure 7.32
Figure 7.33
Figure 7.34
Figure 7.35
Figure 7.36
Figure 7.37
Figure 7.38
Figure 7.39
Figure 7.40
Figure 7.41
Figure 7.42
Figure 7.43
Figure 7.44
Figure 7.45
Figure 7.46
Figure 7.47
Figure 7.48
Figure 7.49
Figure 7.50
Figure 7.51
Figure 7.52
Figure 7.53
Figure 7.54
Figure 7.55
Figure 7.56
Figure 7.57
Figure 7.58
Figure 7.59
Figure 7.60
Figure 7.61
Figure 7.62
Figure 7.63
Figure 7.64
Figure 7.65
Figure 7.66
Figure 7.67
Figure 7.68
Figure 7.69
Figure 7.70
Figure 7.71
Figure 7.72
Figure 7.73
Figure 7.74
Figure 7.75
Figure 7.76
Figure 7.77
Figure 7.78
Figure 7.79
Figure 7.80
Figure 7.81
Figure 7.82
Figure 7.83
Figure 7.84
Figure 7.85
Figure 7.86
Figure 7.87
Figure 7.88
Table 2.1
Table 2.2
Table 2.3
Table 2.4
Table 3.1
Table 4.1
Table 4.2
Table 5.1
Table 5.2
Table 5.3
Table 5.4
Table 5.5
Table 5.6
Table 6.1
Table 6.2
Table 6.3
Table 6.4
Table 6.5
Table 6.6
Table 6.7
Table 6.8
Table 6.9
Table 7.1
Table 7.2
Table 7.3
Table 7.4
Table 7.5
Table 7.6
Table 7.7
Table 7.8
Table 7.9
Table 7.10
Table 7.11
Vallet-Regi, M. (ed.)
Bio-Ceramics with Clinical Applications
2014
Print ISBN: 978-1-118-40675-5; also available in electronic formats
Taubert, A., Mano, J.F., Rodríguez-Cabello, J.C. (eds.)
Biomaterials Surface Science
2013
Print ISBN: 978-3-527-33031-7; also available in electronic formats
Pompe, W., Rödel, G., Weiss, H., Mertig, M.
Bio-Nanomaterials
Designing materials inspired by nature
2013
Print ISBN: 978-3-527-41015-6; also available in electronic formats
Santin, M., Phillips, G.J. (eds.)
Biomimetic, Bioresponsive, and Bioactive Materials
An Introduction to Integrating Materials with Tissues
2012
Print ISBN: 978-0-470-05671-4; also available in electronic formats
Jones, J.J. (ed.)
Bio-Glasses – An Introduction
2012
Print ISBN: 978-0-470-71161-3; also available in electronic formats
Mano, J.F. (ed.)
Biomimetic Approaches for Biomaterials Development
2012
Print ISBN: 978-3-527-32916-8; also available in electronic formats
Riedel, R., Chen, I. (eds.)
Ceramics Science and Technology
4 Volume Set
2006
Print ISBN: 978-3-527-31149-1; also available in electronic formats
Robert B. Heimann and Hans D. Lehmann
The Authors
Prof. Dr. Robert B. Heimann
Am Stadtpark 2A
02826 Görlitz
Germany
Dipl.-Chem Hans D. Lehmann
Jauernicker Str. 19
02826 Görlitz
Germany
Cover
“Künstliches Hüftgelenk 2. Source: Fotolia Cpsdesign 1”
All books published by Wiley-VCH are carefully produced. Nevertheless, authors, editors, and publisher do not warrant the information contained in these books, including this book, to be free of errors. Readers are advised to keep in mind that statements, data, illustrations, procedural details or other items may inadvertently be inaccurate.
Library of Congress Card No.: applied for
British Library Cataloguing-in-Publication Data
A catalogue record for this book is available from the British Library.
Bibliographic information published by the Deutsche Nationalbibliothek
The Deutsche Nationalbibliothek lists this publication in the Deutsche Nationalbibliografie detailed bibliographic data are available on the Internet at <http://dnb.d-nb.de>.
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Boschstr. 12, 69469 Weinheim, Germany
All rights reserved (including those of translation into other languages). No part of this book may be reproduced in any form – by photoprinting, microfilm, or any other means – nor transmitted or translated into a machine language without written permission from the publishers. Registered names, trademarks, etc. used in this book, even when not specifically marked as such, are not to be considered unprotected by law.
Print ISBN: 978-3-527-33743-9
ePDF ISBN: 978-3-527-68402-1
ePub ISBN: 978-3-527-68400-7
Mobi ISBN: 978-3-527-68401-4
oBook ISBN: 978-3-527-68229-4
This introductory text deals predominately with calcium phosphate-based bioceramic materials that are now ubiquitously used in clinical applications to coat the surfaces of metallic endoprosthetic and dental implants that aim at replacing lost body parts or restoring functions to diseased or damaged tissues of the human body. The authors have written the text from a materials scientist's point of view. Hence, its main subject matter concerns the technology of coating deposition as well as the description of properties of bioceramic coatings including their in vitro alteration and testing in contact with simulated body fluids. We will also provide some salient information on in vivo coating–tissue interactions within the natural environment of the living body. Relevant information gained from experimental animal models will be described, without diving too deeply into the biomedical, physiological and endocrinological background.
Calcium phosphates are harbingers of life. They play a paramount role on Earth as one of the essential basic building blocks of living matter. Hydroxyapatite–collagen composite scaffolds provide the mechanical supporting strength and resilience of the gravity-defying bony skeletons of all vertebrates. The dentine and enamel of teeth are likewise based on these materials. However, natural biological apatite–collagen composites provide not only strength but also flexibility, their porous structure allowing exchange of essential nutrients, and a biologically compatible resorption and precipitation behaviour under appropriate physical and chemical conditions that control the build-up by osteoblasts and resorption by osteoclasts within bony matter. Hence, the calcium-deficient defect hydroxyapatite in bone is a reservoir of phosphorus that can be delivered to the body on demand (Pasteris, Wopenka and Valsami-Jones, 2008).
Nevertheless, if one considers the low abundance of phosphorus in the Earth's crust of slightly less than 0.1 mass%, it is a remarkably odd and puzzling choice of Nature to construct many critical pathways of both plant photosynthesis and animal metabolism around this exceedingly rare element (Westheimer, 1987; Filippelli, 2008). Apart from building up the skeleton of vertebrates, biological phosphate compounds are engaged in fuelling the energetic requirements of the photosynthetic pathway of plants called the Calvin–Benson cycle as well as the intercellular energy transfer within the mitochondria of animals that both rely on adenosine triphosphate (ATP). ATP releases the energy needed to sustain the metabolic processes when reduced to adenosine diphosphate (ADP). Hence, this unique energetic contribution of the phosphate groups is central to the functioning of ATP, arguably the most abundant biological molecule in Nature. Furthermore, deoxyribonucleic acid (DNA) as the carrier of the genetic information code owes its double helical structure to phosphate ester bridges that link the two strands of the helix, and are composed of the four nucleobases, the purine-based adenine and guanine, and the pyrimidine-based thymine and cytosine. Lastly, phospholipid bilayers are the main structural components of all cellular membranes that isolate the cell interior from its surrounding, potentially hostile environment. Most phospholipids contain a glycerol-derived diglyceride, a phosphate group, and a simple organic molecule such as choline, a quaternary 2-hydroxy-N,N,N-trimethylethanammonium salt.
The inorganic calcium phosphate minerals most ubiquitously occurring in Nature belong to the apatite group in its many crystal chemical expressions such as hydroxyapatite, fluorapatite and chlorapatite as well as other calcium orthophosphates such as monetite, brushite and whitlockite. While in the past there has been general agreement that these calcium phosphate-based minerals are the most important reservoirs supplying life on Earth with essential phosphorus, more recently feldspars came into focus as a hidden source of phosphorus. It happens that in feldspars P5+ is able to replace tetrahedrally coordinated Si4+ by coupled substitution with Al3+ to maintain charge balance, that is (London et al., 1990; Manning, 2008). Considering the abundance of feldspars in the Earth's crust, and the easy accessibility for plants and soil biota of their P-containing weathering products, predominately clays, feldspars may indeed be a much more significant source of phosphorus than apatites (Parsons, Lee and Smith, 1998).
Considering the importance of the structure of bone as a biocomposite of Ca-deficient defect hydroxyapatite and triple helical strands of collagen I, it is not surprising that as early as about 40 years ago synthetic hydroxyapatite was suggested as a biocompatible artificial material for incorporation in the human body. Hydroxyapatite was used in the form of densified implants for dental root replacement (Denissen and de Groot, 1979) and as a suitable material for filling bone cavities, for fashioning skeletal prostheses (Hulbert et al., 1970) and for coatings hip endoprosthetic devices (Ducheyne et al., 1980; León and Jansen, 2009). Since then research into the biomedical application of calcium phosphate as osseoconductive coatings has virtually exploded. Many deposition methods were experimentally and some, eventually, clinically evaluated that range from biomimetical processing routes intended to mimic Nature's low temperature, template-mediated biomineralisation pathways (Bryksin et al., 2014) to surface-induced mineralisation (SIM), to electrochemical and electrophoretic deposition, to plasma-assisted metal–organic chemical vapour deposition (PA-MOCVD), to atmospheric plasma spraying (APS) or suspension plasma spraying (SPS) (Campbell, 2003). This treatise will review many of these deposition techniques and will thus provide up-to-date information on the resulting bioceramic coatings, their structure, composition and biomedical functions (see Heness and Ben-Nissan, 2004; Sarkar and Banerjee, 2010; Ducheyne et al., 2011; Heimann, 2012; Dorozhkin, 2012; Zhang, 2013; Surmenev, Surmeneva and Ivanova, 2014). In short, the present book intends to act as a primer to introduce non-specialists to the wide-reaching field of bioceramic coatings that are being designed, developed and tested with the aim to alleviate medical deficiencies and the associated suffering of millions of people afflicted with joint and dental maladies.
During the last several decades, research into bulk bioceramics and bioceramic coatings has emerged as a hot topic among materials scientists. Virtually thousands of papers can now be found in relevant journals (see Appendix) and on the Internet. Attempting to treat this vast field in an encyclopaedic fashion is clearly impossible as each day new contributions are being published with ever-increasing speed and regularity. Hence, trying to keep abreast with these developments is akin to shooting at a very fast moving target. The best that one can do is to provide snapshots of currently available information and attempting to separate the wheat from the chaff whenever possible. To paraphrase the resigning comment by the great German poet Johann Wolfgang von Goethe, uttered in his autobiography ‘Out of my Life: Poetry and Truth’: ‘Such (…) work will never be finished; one has to declare it finished when one has done the utmost in terms of time and circumstances’.
As a parting glance, it should be mentioned that during the preparation of the text, three imaginary readers have intently looked over our shoulder: an interested layperson, a professional working in the area of the subject matter of this treatise, and a diligent student whose interest and knowledge are located somewhere in-between. The layperson may not be conversant with many of the subtleties expounded throughout our text but may be eager to penetrate deeper into the subject of bioceramic coatings. Hence, to somewhat relieve this potential reader from the burden of looking up non-familiar analytical techniques and special scientific terms in other textbooks or encyclopaedias, we have provided in the Chapters 5 and 7 short explanations that precede the more detailed descriptions of coating deposition techniques, and characterisation and testing procedures.
Our second imaginary reader is the professional who may look into specific chapters to extract expert knowledge. He or she will act as a thorough if not harsh critic of our endeavour, and will undoubtedly castigate us for having left out crucial aspects of the subject matter treated in this book. This expert may also criticise us for having used inappropriate terms and faulty connections among materials science and biomedical facts. Alas, we used such possibly scientifically shaky explanations to satisfy the limited level of understanding of imaginary reader #1. The expert may also accuse us of having skimmed over the deep subtleties of the subject, and, in particular, not having given due consideration to those aspects in which he or she has earned scientific standing and international acclaim. However, during the vast progress made in developing increasingly sophisticated techniques to design and engineer bioceramic materials including coatings, many unexplored vestiges and nooks and crannies have been left behind the speedily advancing battle lines that require additional and more detailed studies. Some of the content of this book has been devoted to ‘mopping up’ such neglected research topics. These topics notwithstanding, we are much aware of deficiencies in our approach and hence ask imaginary reader #2 for understanding and kind forgiveness.
Our third imaginary reader is a student who may want to inform himself/herself quickly on the general subject of bioceramic coatings, their preparation technology, materials science, uses, properties, as well as analytical characterisation, and in vitro and in vivo testing. We are hopeful that our treatise will provide the information sought by this student without forcing him/her to delve into the abyss of specialised literature. Hence, imaginary reader #3 may benefit from our concise and condensed approach in as much as it will provide relief from ploughing through piles of original papers scattered over dozens of scientific journals.
The dangers of attempting to satisfy both the curiosity and the need for knowledge of these three imaginary readers are obvious. The only thing we can hope for is, on the one hand, to have avoided to be over the head of the layperson, and on the other hand, to have provided enough scientific ‘meat’, limited as it may be, to earn the approval of the expert and the appreciation of the student as well. Readers trained in the realm of medical and biological sciences will likely appreciate the materials science aspects of bioceramic coatings whereas those educated in materials science may find the biomedical content of the book enlightening and useful. To satisfy both types of our potential audience is intrinsically difficult, and should we have failed here and there in this endeavour, we beg the gentle reader for pardon.
Robert B. HeimannHans D. Lehmann
Bryksin, A.V., Brown, A.C., Baksh, M.M., Finn, M.G., and Barker, T.H. (2014) Learning from nature – novel synthetic biology approaches for biomaterial design.
Acta Biomater.
,
10
(4), 1761–1769.
Campbell, A.A. (2003) Bioceramics for implant coatings.
Materialstoday
,
6
, 26–30.
Denissen, H.W. and de Groot, K. (1979) Immediate dental root implants from synthetic dense calcium hydroxylapatite.
J. Prosthet. Dent.
,
42
, 551–556.
Dorozhkin, S.V. (2012) Calcium orthophosphate coatings, films and layers.
Prog. Biomater.
,
1
, 1 (40 pp.).
Ducheyne, P., Healy, K., Hutmacher, D.E., Grainger, D.W., and Kirkpatrick, J.P. (eds) (2011)
Comprehensive Biomaterials
, Elsevier, Amsterdam, ISBN: 978-0-08-055302-3.
Ducheyne, P., Hench, L.L., Kagan, I., Martens, A., Bursens, A., and Mulier, J.C. (1980) Effect of hydroxyapatite impregnations on skeletal bonding of porous coated implants.
J. Biomed. Mater. Res.
,
14
, 225–237.
Filippelli, G.M. (2008) The global phosphorus cycle: past, present and future.
Elements
,
4
, 89–95.
Heimann, R.B. (ed) (2012)
Calcium Phosphate – Structure, Synthesis, Properties and Applications
, Biomedical Research Trends, Nova Science Publishers Inc., New York, 498 pp., ISBN: 978-1-62257-299-1.
Heness, G. and Ben-Nissan, B. (2004) Innovative bioceramics.
Mater. Forum
,
27
, 107–114.
Hulbert, S.F., Young, F.A., Mathews, R.S., Klawitter, J.J., Talbert, C.D., and Stelling, F.H. (1970) Potential of ceramic materials as permanently implantable skeletal prostheses.
J. Biomed. Mater. Res.
,
4
, 433–456.
León, B. and Jansen, J.A. (eds) (2009)
Thin Calcium Phosphate Coatings for Medical Implants
, Springer, New York, 326 pp., ISBN: 978-0-387-77718-4.
London, D., Černý, P., Loomis, J.L., and Pan, J.J. (1990) Phosphorus in alkali feldspars of rare-element granitic pegmatites.
Can. Mineral.
,
28
, 771–786.
Manning, D.A.C. (2008) Phosphate minerals, environmental pollution and sustainable agriculture.
Elements
,
4
, 105–108.
Parsons, J., Lee, M.R., and Smith, J.V. (1998) Biochemical evolution II: origin of life in tubular microstructures on weathered feldspar surfaces.
Proc. Natl. Acad. Sci. U.S.A.
,
95
, 15173–15176.
Pasteris, J.D., Wopenka, B., and Valsami-Jones, E. (2008) Bone and tooth mineralization: why apatite?
Elements
,
4
, 97–104.
Sarkar, R. and Banerjee, G. (2010) Ceramic-based biomedical implants.
Interceram
,
2
, 98–102.
Surmenev, R.A., Surmeneva, M.A., and Ivanova, A.A. (2014) Significance of calcium phosphate coatings for the enhancement of new bone osteogenesis – a review.
Acta Biomater.
,
10
, 557–579.
Westheimer, F.H. (1987) Why nature chose phosphates.
Science
,
235
, 1173–1178.
Zhang, S. (ed) (2013)
Hydroxyapatite Coatings for Biomedical Applications
, Advances in Materials Science and Engineering, CRC Press, 469 pp., ISBN: 978-1-4398-8693-9.
AAGR
average annual growth rate
AAS
atomic absorption spectroscopy
a.c.
alternating current
ACP
amorphous calcium phosphate
ADP
adenosine diphosphate
AFM
atomic force microscopy
ALP
alkaline phosphatase
ANOVA
analysis of variance
AO
acridine orange
APS
atmospheric plasma spraying
ATP
adenosine triphosphate
A/W
apatite/wollastonite
ATZ
alumina-toughened zirconia
BCA
bone-like carbonated apatite
BCP
biphasic calcium phosphate
bFGF
basic fibroblast growth factor
BIC
countries Brasil, India, China
BIR
bone ingrowth rate
BMD
bone mineral density
BMP
bone morphogenetic protein
BMSC
bone marrow stromal cell
BP
bisphosphonate
BRIC
countries Brasil, Russia, India, China
BSA
bovine serum albumin
BSE
back-scattered electron
BSP
bone sialoprotein
CAGR
compound annual growth rate
calcein-AM
acetoxymethyl-ester of calcein
CaP
calcium phosphate (in a general sense)
Ca-PSZ
calcia-partially stabilised zirconia
CCC
carbon–carbon composite
CCD
charge-coupled device
CCDS
computer-controlled detonation spraying
CCVD
combustion chemical vapour deposition
CDHAp
calcium-deficient hydroxyapatite
CEC
Fédération Européene des Fabricants de Carreaux Ceramiques
Ce-TZP
ceria-stabilised tetragonal zirconia polycrystal
CFD
computational fluid dynamics
CFRP
carbon fibre-reinforced polymer
CGDS
cold gas dynamic spraying
CHAp
carbonated hydroxyapatite
CiA
citric acid
CL
cathodoluminescence
ClAp
chlorapatite
CMP
calcium metaphosphate
CNS Glasses
calciumoxide-sodiumoxide-siliciumdioxide glasses, see also NCS
CNT
carbon nanotubes
CP
cross polarisation (in NMR)
CPM
calcium dihydrogenphosphate monohydrate
CPP
calcium pyrophosphate
CPPD
calcium pyrophosphate dihydrate
cp-titanium
commercially pure titanium
CR
corrosion rate
CRM
confocal Raman microscopy
CTE
coefficient of thermal expansion
CTO
calcium titanate, CaTiO3, perovskite
CVD
chemical vapour deposition
d.c.
direct current
DCPA
dicalcium phosphate anhydrate
DCPD
dicalcium phosphate dihydrate
DDA
degree of deacylation
DFT-LDA
density-functional theory with local-density approximation
DGS
detonation gun spraying
DIPS
diffusion-induced phase separation
DLC
diamond-like carbon
DMEM
Dulbecco's modified eagle's medium
DNA
deoxyribonucleic acid
DOE
design of experiment
DS
detonation spraying
DTA
differential thermal analysis
EBAD
electron beam assisted deposition
EBPVD
electron beam physical vapour deposition
EBSD
electron back-scattered diffraction
ECD
electrochemical deposition
ECF
extracellular fluid
ECM
extracellular matrix
ED
electron diffraction
EDS
energy dispersive spectroscopy
EDTA
ethylenediaminetetraacetic acid (sequestrant)
EDX
energy-dispersive X-ray spectroscopy
EELS
electron energy loss spectroscopy
EIS
electrochemical impedance spectroscopy
ELISA
enzyme-linked immunosorbent assay
EPD
electrophoretic deposition
EPMA
electronic probe microanalysis
EPR
electron paramagnetic resonance (spectroscopy), see also ESR
ESEM
environmental scanning electron microscopy
ESR
electron spin resonance (spectroscopy), see also EPR
EtBr
ethidium bromide
EXAFS
extended X-Ray absorption fine structure
EXSY
exchange spectroscopy (in NMR)
FA-CVD
flame-assisted chemical vapour deposition
FE-SEM
field emission scanning electron microscopy
FFT
fast Fourier transform
FGC
functional gradient composites
FGHA
functionally graded hydroxyapatite
FGM
functionally graded material
FHAp
fluorine-doped hydroxyapatite
FIB
focused ion beam
FTIR
Fourier transform infrared spectroscopy
FTRS
Fourier transform Raman spectroscopy
GD
glow discharge
GN
graphene nanosheet
HA, HAp
hydroxyapatite
HAV
hyaluronic acid visco-supplementation
HBDC
human bone-derived cell
hBMSC
human bone marrow stromal cell
HBSS
Hank's balanced salt solution
HCA
hydroxycarbonate apatite
HCP
heptacalcium phosphate
HDPE
high-density poly(ethylene)
hECF
human extracellular fluid
HEPES
2-(4-(2-
h
ydroxy
e
thyl)-1-
p
iperazinyl)-
e
than
s
ulfonic acid (buffer)
HETCOR
heteronuclear correlation
hICF
human intracellular fluid
hISF
human interstitial fluid
hMSC
human mesenchymal stem cell
HRTEM
high resolution transmission electron microscopy
HSTC
hierarchical-structured titanium coating
hUVEC
human umbilical vein endothelial cell
HVOF
high velocity oxyfuel spraying
HVSFS
high velocity suspension flame spraying
IBAD
ion beam assisted deposition
IBSD
ion beam sputtering deposition
ICP/MS
inductively coupled plasma/mass spectroscopy
ICPS
inductively coupled plasma spraying
IGF
insulin-like growth factor
IPS
induction plasma spraying
IR
infrared (spectroscopy)
ISE
indentation size effect
ISQ
implant stability quotient
KDR
kinase insert domain receptor
LASAT
laser shock adhesion test
LEPS
low-energy plasma spraying
LGN
laser gas nitriding
LPCVD
low pressure chemical vapour deposition
LPPS
low pressure plasma spraying
LRS
laser Raman spectroscopy
MAO
micro-arc oxidation
MAPLE
matrix-assisted pulsed laser evaporation
MAS
magic angle spinning (technique in NMR)
MCSF
macrophage colony-stimulating factor
MEMS
microelectromechanical system
Mg-PSZ
magnesia-partially stabilised zirconia
M(I)PS
micro-plasma spraying
MRI
magnetic resonance imaging
MSC
marrow stem cell
MTT
3-(4,5-di
m
ethyl
t
hiazol-2-yl)-2,5-diphenyl
t
etrazolium bromide (dye)
MWCNT
multi-walled carbon nanotubes
NAD
nicotinamide adenine dinucleotide
NCS
sodiumoxide calciumoxide silicate glasses, see also CNS
NASICON
sodium super ionic conductor (structural family)
NMR
nuclear magnetic resonance (spectroscopy)
NZP
sodium zirconium phosphate
OAp
oxyapatite
OC
osteocalcin
OCP
octacalcium phosphate
OES
optical emission spectroscopy
OHAp
oxyhydroxyapatite
OP
osteopontin
OPG
osteoprotegerin
PA
polyamid
PAA
poly(acrylic acid)
PA-MOCVD
plasma-assisted metal-organic chemical vapour deposition
PBC
periodic bond chain
PBTCA
2-phosphonobutane-1,2,4-tricarboxylic acid (dispersant)
PC
pulsed current
PCA
percentage of coated area
PCL
poly(ε-caprolactone)
PDA
post deposition annealing
PDGF
platelet-derived growth factor
PDOP
poly(dopamine)
PE
poly(ethylene)
PECVD
plasma-enhanced chemical vapour deposition
PEEK
poly(etheretherketone)
PEG
poly(ethyleneglycol)
PEI
poly(ethylene imine)
PEO
plasma electrolytic oxidation
PE-UHMW
poly(ethylene) ultra-high molecular weight
PGA
poly(glutamic acid)
PIXE
particle- or proton-induced X-ray emission
PLA
poly(lactic acid)
PLD
pulsed laser deposition
PLGA
poly(lactic-
co
-glycolic acid)
PMMA
poly(methylmethacrylate)
PSZ
partially-stabilised zirconia
PVD
physical vapour deposition
RANK(L)
receptor activator of nuclear factor kappa (ligand)
REE
rare earth elements
RF, r.f.
radio frequency
RFA
resonance frequency analysis
rhBMP
recombinant human bone morphogenetic protein
RIPS
reaction-induced phase separation
RNA
ribonucleic acid
ROS
reactive oxygen species
r-SBF
revised simulated body fluid (see also: SBF-H,
Table 7.8
)
RT-PCR
reverse transcription polymerase chain reaction
RTQ
removal torque
RUNX
2
runt-related transcription factor 2
SAED
selected area electron diffraction
SAM
self-assembled monolayer
SAXS
small-angle X-ray scattering
SBF
simulated body fluid
SCE
standard calomel electrode
SDE
statistical design of experiments
SEM
scanning electron microscopy
Si-HAp
silicate-doped hydroxyapatite
SIM
surface-induced mineralisation
SIMS
secondary ion mass spectrometry
SOFC
solid oxide fuel cell
SPC
statistical process control
SPM
scanning probe microscopy
SPPS
solution precursor plasma spraying
SPS
suspension plasma spraying
Sr-HAp
strontium-doped hydroxyapatite
SRO
short range order
SS
stainless steel
STEM
scanning transmission electron microscopy
SZS
strontium-zinc-silicium ceramic
TCP
tricalcium phosphate
TCPS
tissue culture-grade polystyrene
TDHP
tetracalcium dihydrogenhexaphosphate
TEM
transmission electron microscopy
TERS
tip-enhanced Raman spectroscopy
TGA
thermogravimetric analysis
TGF
transforming growth factor
THA
total hip arthroplasty
THR
total hip replacement
TiCN
titanium carbonitride
TiN
titanium nitride
TIPS
temperature-induced phase separation
TKA
total knee arthroplasty
TL
thermoluminescence
TLR
toll-like receptor
TMCP
transition metal-substituted calcium phosphate
TNF
tumor necrosis factor
ToF-SIMS
time-of-flight secondary ion mass spectrometry
TRAP
tartrate-resisting acid phosphatase
TRIS
tris(hydroxymethyl)-aminomethan (buffer solution)
TTCP, TetrCP
tetracalcium phosphate
TZP
tetragonal zirconia polycrystal
UHMWPE
ultra-high molecular weight poly(ethylene)
UV
ultraviolet
VCS
vacuum/reduced pressure cold spraying
VEGF
vascular endothelial growth factor
VPS
vacuum plasma spraying
XANES
X-ray absorption near-edge structure
XPS
X-ray photoelectron spectroscopy
XRD
X-ray diffraction
Y-PSZ
yttrium-partially stabilised zirconia
YSZ
yttria-stabilised zirconia
Y-TZP
yttria-stabilised tetragonal zirconia polycrystal
ZA
zoledronic acid
ZTA
zirconia-toughened alumina
μCT
micro computed tomography
In this chapter, we will attempt to trace briefly the long and sometimes anfractuous history of important bioceramics including coatings. Emphasis will be put on the bioinert ceramics alumina and zirconia, as well as on bioactive, that is osseoconductive calcium phosphates.
Alum (potassium aluminium sulfate, KAl(SO4)2·12H2O) was already known in antiquity (‘sal sugoterrae’ of Pliny), and widely utilised in dying of wool, as a coagulant to reduce turbidity in water, and as a medicine to remedy various ailments based on its astringent, haemostatic and antibiotic nature. In 1754, the German (al)chemist Andreas Sigismund Marggraf (1709–1782) was first to isolate aluminium oxide (‘Alaunerde’) from alum but was unable to determine its exact composition (Marggraf, 1754, 1761). Between 1808 and 1810, Sir Humphrey Davy tried unsuccessfully to reduce the oxide to metallic aluminium, a feat that was accomplished later by Oerstedt (1825) by heating aluminium chloride with potassium amalgam.
Aluminium oxide (alumina) has also been known since ancient times and several isolated uses have been reported for emery (smirgel), an impure corundum occurring, for example, on the Greek island of Naxos. Gorelick and Gwinnett (1987) have shown that emery was likely employed as an abrasive for drilling of hardstone beads and cylinder seals during ancient Mesopotamian times. In addition, finely ground emery powder was arguably used by the famous Greek sculptor Pheidias as a separation medium to avoid adhesion of heated glass sheets to clay-based moulds. The corrugated glass sheets thus obtained were likely designed to be clothing folds adorning the himation (ancient Greek cloak) of the giant statue of Zeus in his Olympia temple (Heilmeyer, 1981).
The unique mechanical and thermal properties of alumina have spurred its utilisation as high temperature-, wear- and corrosion-resistant ceramics. Besides this, its first application as biomaterial was suggested by Rock (1933) in a Deutsches Reichspatent, followed by a patent issued to Sandhaus (1966) for the use of alumina for dental and jaw implants. However, it was only after the groundbreaking paper by Boutin (1972) that alumina took off on its worldwide triumphal course as a suitable ceramic material for femoral balls of hip endoprostheses.
Figure 1.1 shows the development of bioinert and bioactive ceramics (Rieger, 2001). In 1920, tricalcium phosphate (TCP) was suggested as a bioresorbable ceramic material for filling of bone gaps that, however, was unable to bear extended loads (Heughebaert and Bonel, 1986). Alumina entered the scene around 1930 (Rock, 1933) and was subsequently much improved in terms of its compressive strength and fracture toughness by painstaking engineering of its purity and ever decreasing grain size down to the nano-scale level. This development led to orthopaedic structural ceramic products such as Ceraver-Osteal® (Boutin, 1972), Keramed® (Glien, Kerbe and Langer, 1976), Frialit® (Griss and Heimke, 1981), and finally the family of Biolox® ceramics by Feldmühle, later CeramTec companies (Dörre and Dawihl, 1980, see also Clarke and Willmann, 1994) as well as BIONIT® manufactured by Mathys Orthopädie GmbH (Bettlach, Switzerland). The current high-end product of CeramTec is Biolox® delta, a zirconia-toughened alumina (ZTA) alloy reinforced with chromia as a crack arrester (see Chapter 4.1.1).
Figure 1.1 Application of bioceramics in medical devices: 100 years of history. (Adapted from Rieger (2001), and adjusted to current developments.)
Evaluation of biocompatibility resulted chiefly from clinical experience (Boutin, 1972; Hulbert, Morrison and Klawitter, 1972; Griss et al., 1973; Griss, 1984; Mittelmeier, Heisel and Schmitt, 1987) supported by in vitro cytotoxicity testing (for example Catelas et al., 1998; Nkamgueu et al., 2000, and many other contributors).
Zirconium dioxide was first extracted from the mineral zircon (zirconium silicate, ZrSiO4) by the German chemist Martin Heinrich Klaproth (1743–1817) in 1787, using the yellowish orange-coloured, transparent gemstone jacinth (hyacinth) from Ceylon as starting material. Zircon has been known to man for a very long time; its name presumably originated from the Arabian word ‘zargun’, meaning ‘gold-coloured’ that etymologically is related to the ancient Persian words ‘zarenu’ (gold) and ‘gauna’ (colour) (Vagkopoulou et al., 2009). In 1824, the Swedish chemist Jöns Jakob Berzelius (1779–1848) was first to isolate metallic zirconium by reduction of K2ZrF6 with potassium.
For the following 150 years, zirconium as well as zirconia were considered mere scientific curiosities without any substantial technological merits apart from limited utilisation of zirconia in heavy-duty bricks for high temperature applications and for special glasses (Morey, 1938) with a high index of refraction. It was only in 1969 that the first scientific study of the outstanding biomedical properties of zirconia emerged (Helmer and Driskell, 1969). Subsequently, it was discovered that alloying zirconia with oxides such as yttria, calcia, magnesia and others was able to stabilise its tetragonal modification thus halting the structurally and mechanically deleterious phase transition from the tetragonal to the monoclinic phase (Garvie and Nicholson, 1972). This discovery allowed using the so-called transformation toughening of zirconia to produce ceramics with unsurpassed crack resistance (‘ceramic steel’) (Garvie, Hannink and Pascoe, 1975). Still later, it was found that even unalloyed microcrystals of zirconia could be stabilised against transformation if the tetragonal high temperature phase has a reduced surface free energy with respect to the monoclinic low temperature structure (Garvie, 1978). These partially stabilised tetragonal zirconia polycrystalline ceramics (TZP) are characterised by a structure of high density, small grain size and high purity that jointly elicit strength and fracture toughness unusually high for a ceramic material. Consequently, such ceramics were employed to fashion femoral ball heads starting by the mid-eighties of the past century (Cales and Stefani, 1995, Figure 1.1) and, later, to make dental parts of all kinds including dental roots, inlays and veneers.
Starting in the 1980s, besides structural and mechanical investigations of zirconia (see, for example Rühle, Claussen and Heuer, 1983), studies on its biocompatibility moved into the limelight as evidenced, for example, by the pioneering work of Garvie et al. (1984), Christel et al. (1989) and Hayashi et al. (1992). Their work triggered a virtual avalanche of research that used increasingly sophisticated evaluation techniques of material properties. In addition, studying the in vitro and in vivo biomedical performance of zirconia in contact with biofluid and tissues established zirconia as a viable bioceramics (for example Piconi and Maccauro, 1999; Piconi et al., 2003; Fini et al., 2000; Clarke et al., 2003; Thamaraiselvi and Rajeswari, 2004; Manicone, Rossi Iommetti and Raffaeli, 2007; Afzal, 2014). Later, several applications emerged as bond coats as well as reinforcing particles for hydroxyapatite coatings for implants.
Today, a large segment of utilisation of zirconia as colour-adapted tooth veneers in dental restoration exists (Cales, 1998). At this point, it is appropriate to mention the ancient French dental doctor Pierre Fauchard (1678–1761) who may be considered the vanguard of modern tooth restoration. He has been credited with recognising the potential of porcelain enamels and initiating research with porcelain to imitate the natural colour of teeth and gingival tissue (Fauchard, 1728).
Calcium orthophosphates have been known to be associated with organic tissue, diligently researched and eventually applied for at least 250 years. As early as 1769, the Swedish chemists Johan Gottlieb Gahn and Carl Wilhelm Scheele discovered that TCP, Ca3(PO4)2 could be obtained by burning bone, and they continued to isolate elemental phosphorus by reducing acid-treated bone ash with charcoal, and distilling off the escaping phosphorus vapour in a retort (Threlfall, 1951). In fact, bone ash was the predominant source of phosphorus until the 1840s when mining, first of tropical island deposits formed from bird and bat guano and, later phosphate rock, took over.
The preparation of pure tricalcium orthophosphate by an alternate route was already described 200 years ago in an encyclopaedia as follows:
Phosphate of lime, proper. As this salt constitutes the basis of bones, it is not necessary to prepare it artificially. It may be obtained in a state of purity by the following process: Calcine the bones to whiteness, reduce them to powder, and wash them repeatedly with water, to separate several soluble salts, which are present. Dissolve the whole in muriatic acid, and precipitate by means of ammonia. The precipitate, when well washed and dried, is pure phosphate of lime (Good, Olinthus and Newton, 1813).
A chemistry textbook for students of medicine written in 1819 (Bache, 1819) states:
Phosphate of lime is a white insoluble powder, destitute of taste, and unaltered by exposure to air. It is soluble in hydrochloric (muriatic) and nitric acids, and may be precipitated from solution in them by means of ammonia. When exposed to a very violent heat, it undergoes a kind of fusion, and is converted into white semi-transparent porcelain.
Heated and crushed animal bones were used copiously in making bone China, predominately in Britain, commencing around the mid-eighteenth century (Heimann, 2012; Heimann and Maggetti, 2014). As it turned out, by the end of the eighteenth century much research had been performed on calcium phosphates, which involved the names of many renowned scientists of the time including Klaproth, Proust, Lavoisier, Vauquelin and de Fourcroy. Recently, these research activities were exhaustively summarised by Dorozhkin (2013).
The nineteenth century saw increasingly important research on calcium phosphates, culminating in a series of contributions by Mitscherlich (1844), Berzelius (1845), Fresenius (1867), Warington (1871) and Church (1873). In our context, particular attention has to be paid to Warington's paper that describes the dissolution of bone ash in the presence of carbonated water, an important precondition for the agricultural use of calcium phosphates, and to the contribution by Church who was presumably the first to determine and publish the exact formula of fluorapatite.
The knowledge of the presence of calcium phosphates in bone (De Fourcroy et al., 1788; Parr, 1809; von Bibra, 1844), teeth (Davy, 1814), blood and milk (De Fourcroy, 1804), urine (De Fourcroy et al., 1788) as well as urinary and renal calculi (Colon, 1770; Pemberton, 1814) was solidly established by the early nineteenth century. Additional historic evidence for this has been painstakingly recorded by the prolific chronicler of calcium phosphates, Dorozhkin (2012), quoting no less than 279 references on the history of calcium phosphate research. Among these treasures there appears faint indication that several calcium phosphate phases, important for biomineralisation, were already known, suspected or suggested early on such as amorphous calcium phosphate, ACP (Brande and Taylor, 1863) and octacalcium phosphate, OCP as well as dicalcium phosphate dihydrate, DCPD (brushite) (Warington, 1866).
The discoveries of X-ray radiation by Röntgen (1895) and its application to crystal structure analysis by Bragg father and son (Bragg, 1921) moved research on calcium phosphates from a descriptive to a predictive acquisition of knowledge, and allowed investigating phase transitions in unprecedented detail. Consequently, a series of studies emerged in early 1930 using X-ray diffraction (XRD) as an important and versatile tool to assess the structural chemistry of calcium phosphates in general and hydroxyapatite in particular (Hendricks et al., 1931; Roseberry, Hastings and Morse, 1931; Trömel, 1932; Bredig, 1933; Bredig, Franck and Füldner, 1933). De Jong (1926) was first to identify the structure of the calcium phosphate phase in bone as being akin to geological apatite that has long been known as an important phosphate mineral (Werner, 1788). From their XRD studies Hendricks et al. (1931) concluded that animal bone consisted of carbonate apatite, Ca10[CO3(PO4)6]·H2O, a compound isomorphous with fluorapatite. They also reported the existence of oxyapatite, Ca10O(PO4)6 that could be prepared by heating hydroxyapatite or bone at 900 °C until constant weight had been attained. The latter finding met with disagreement by Bredig et al. (1933) who drafted one of the earliest CaO–P2O5 phase diagrams in the absence of water, and first proposed the existence of ‘mixed’ apatites, that is oxyhydroxyapatites Ca10(PO4)6X2mOn (, F; ). However, they denied the existence of a pure stable oxyapatite structure, because in their opinion the X position could not be left empty. Much later, research refuted this contention (see Chapter 6.2.1.4). Bredig et al. (1933) based their conclusion about the non-existence of pure oxyapatite on experimental evidence and went on to postulate the likewise non-existence of TCP with apatite structure, unlike the existence of an isomorphous relationship between pyromorphite, Pb10(PO4)6Cl2 and Pb3(PO4)2 established by Zambonini and Ferrari (1928). The systematic progress of the knowledge gained on the chemical composition and structure of bone mineral, that is Ca-deficient hydroxyapatite was recently reviewed by Rey et al. (2010). The important, but still not quite resolved, role water assumes in the structure of bone was beautifully highlighted by Pasteris (2012).
Considering the importance of the structure of bone as a biocomposite of Ca-deficient defect hydroxyapatite and triple helical strands of collagen I, it is not surprising that as early as about 40 years ago synthetic hydroxyapatite was suggested as a biocompatible artificial material for incorporation in the human body (Jarcho et al., 1976; Jarcho, 1981). In a next step, hydroxyapatite was introduced as a bioactive, that is osseoconductive coating. Its first application was in plasma-sprayed coatings for dental implants, followed by coatings for the stem of hip endoprostheses to improve implant integration with the surrounding bone (Ducheyne et al., 1980; Figure 1.1). Although the preferred deposition technology was and still is atmospheric plasma spraying (APS, León and Jansen, 2009; Heimann, 2010), other techniques abound including low-pressure (vacuum) plasma spraying (VPS, Gruner, 1986) and most recently high-velocity suspension flame spraying (HVSFS, Bolelli et al., 2010). Chapter 5 of this treatise will exhaustively review many deposition techniques. Hydroxyapatite was also utilised in the form of densified implants for dental root replacement (Denissen and de Groot, 1979), as a suitable material for filling bone cavities, and for fashioning skeletal prostheses (Hulbert et al., 1970; Capello and Bauer, 1994).
In 2003, an up-to-date summary of studies was edited by Epinette and Manley (2003), describing the state-of-the-art of hydroxyapatite coatings in orthopaedics as this stood at the close of 2002. This compilation of results was designed to help to answer the still somewhat hotly debated question of whether the favourable results achieved in the short term with this method of biologic fixation of total joint implants has withstood the test of time. The goal of Epinette and Manley's book was mainly to determine if the use of hydroxyapatite coatings for the fixation of orthopaedic implants to bone has been proven by the survivorship and satisfaction of those patients who had received hip and knee implants.
Afzal, A. (2014) Implantable zirconia bioceramics for bone repair and replacement: a chronological review.
Mater Express
,
4
(1), 1–12.
Bache, F. (1819)
A System of Chemistry for the Use of Students of Medicine
, Printed and published for the author William Fry, Philadelphia, PA, 624 pp.
Berzelius, J. (1845) Über basische phosphorsaure Kalkerde.
Justus Liebigs Ann. Chem.
,
53
(2), 286–288.
Bolelli, G., Cannillo, V., Gadow, R., Killinger, A., Lusvarghi, L., Sola, A., and Stiegler, N. (2010) Microstructure and in-vitro behaviour of a novel high-velocity suspension flame sprayed (HVSFS) bioactive glass coating.
Surf. Coat. Technol.
,
205
(4), 1145–1149.
Boutin, P. (1972) L'arthroplastie total de la hanche par prothèse en alumine frittée.
Rev. Chir. Orthop.
,
58
, 229–246.
Bragg, W.H. (1921) Application of the ionisation spectrometer to the determination of the structure of minute crystals.
Proc. Phys. Soc. London
,
33
, 222–224.
Brande, W.T. and Taylor, A.S. (1863)
Chemistry
, Blanchard and Lea, Philadelphia, PA.
Bredig, M.A. (1933) Zur Apatitstruktur der anorganischen Knochen- und Zahnsubstanz. Hoppe-Seyler's.
Z. Physiol. Chem.
,
216
(5-6), 239–243.
Bredig, M.A., Franck, H.H., and Füldner, H. (1933) Beiträge zur Kenntnis der Kalk-Phosphorsäure-Verbindungen II.
Z. Elektrochem.
,
39
(12), 959–969.
Cales, B. (1998) in
Bioceramics 11
(eds T.Z. LeGeros and J.P. LeGeros), World Scientific Publishing, New York, pp. 591–594.
Cales, B. and Stefani, Y. (1995)
Encyclopedic Handbook of Biomaterials and Bioengineering, Part B: Applications
, vol. 1, Marcel Dekker, Inc., New York, Basel, Hong Kong, pp. 415–452.
Capello, W.N. and Bauer, T.W. (1994) in
Bone Implant Interfaces
(ed. H.U. Cameron), Mosby, St. Louis, MO, Baltimore, MD, Boston, MA, pp. 191–202. ISBN: 0-8016-6483-7.
Catelas, I., Huk, O.L., Petit, A., Zukor, D.J., Marchand, R., and Yahia, L. (1998) Flow cytometric analysis of macrophage response to ceramic and polyethylene particles: effects of size, concentration, and composition.
J. Biomed. Mater. Res.
,
41
(4), 600–607.
Christel, P., Meunier, A., Heller, M., Torre, J.P., and Peille, C.N. (1989) Mechanical properties and short-term in-vivo evaluation of yttrium oxide-partially-stabilized zirconia.
J. Biomed. Mater. Res.
,
23
(1), 45–61.
Church, A.H. (1873) New analyses of certain mineral arseniates and phosphates. 1. Apatite; 2. Arseniosiderite; 3. Childrenite; 4. Ehlite; 5. Tyrolite; 6. Wavellite.
J. Chem. Soc.
,
26
, 101–111.
Clarke, I.C., Manaka, M., Green, M.S., Williams, P., Pezotti, G., Kim, Y.-H., Ries, M., Sugano, N., Seidel, L., Delauney, C., Ben Nissan, B., Donaldson, T., and Gustavson, G.A. (2003) Current status of zirconia used in total hip implants.
J. Bone Joint Surg.
,
85A
(Suppl. 4), 73–84.
Clarke, I.C. and Willmann, G. (1994) in
Bone Implant Interfaces
(ed. H.U. Cameron), Mosby, St. Louis, MO, Baltimore, MD, Boston, MA, pp. 203–252. ISBN 0-8016-6483-7.
Colon, P. (1770)
De calculo Renali, theses Anatomicae et Chirurgicae
, Le Prieur [etc.], Paris.
Davy, H. (1814)
Conversations on Chemistry, in which the Elements of that Science are Familiarly Explained and Illustrated by Experiments and Plates
, Didnep's Press [etc.] (quoted after Dorozhkin, 2012).
De Fourcroy, A.F. (1804)
A General System of Chemical Knowledge and its Application to the Phenomena of Nature and Art
, 11 vols, vol. 3, (Translated by W. Nicholson), London, Cadell & Davies.
De Fourcroy, A.T.
et al
. (1788)
Elements of Natural History, and of Chemistry, being the second edition of the elementary lectures on those sciences, first published in 1782, and now greatly enlarged and improved, by the Author, M. de Fourcroy, doctor of the faculty of medicine at Paris, of the Royal Academy of Sciences, andc, andc, andc, Translated into English. With occasional notes, and an historical preface, by the translator
, vol.
IV
, G.G.J. and J. Robinson, Pater-Noster-Row, London, 465 pp. (quoted after Dorozhkin, 2012).
De Jong, W.F. (1926) La substance minerale dans les os.
Recl. Trav. Chim. Pays-Bas Belg.
,
45
, 445–448.
Denissen, H.W. and de Groot, K. (1979) Immediate dental root implants from synthetic dense calcium hydroxylapatite.
J. Prosth. Dent.
,
42
(5), 551–556.
Dorozhkin, S.V. (2012) in
Calcium Phosphate. Structure, Synthesis, Properties, and Applications
, Biochemistry Research Trends (ed. R.B. Heimann), Nova Science Publishers, New York, pp. 1–40. ISBN: 978-1-62257-299-1
Dorozhkin, S.V. (2013) A detailed history of calcium orthophosphates from 1770s till 1950.
Mater. Sci. Eng. C
,
33
(6), 3085–3110.
Dörre, E. and Dawihl, W. (1980) in
Mechanical Properties of Biomaterials
(eds P. Ducheyne and G.W. Hastings), John Wiley & Sons, Ltd, Chichester, pp. 113–127.
Ducheyne, P., Hench, L.L., Kagan, A., Martens, M., Mulier, J.C., and Burssens, A. (1980) The effect of hydroxyapatite impregnation on bonding of porous coated implants.
J. Biomed. Mater. Res.
,
14
, 225–237.
Epinette, J.A. and Manley, M.T. (2003)
Fifteen Years of Clinical Experience with Hydroxyapatite Coatings in Joint Arthroplasty
, Springer. ISBN: 978-2-2070-0508-4.
Fauchard, P. (1728)
Le chirurgien dentiste ou Traite des dents
(engl. transl. by Lindsay, L. (1946)
The Surgeon Dentist
, Butterworth & Co, London.
Fini, M., Giavaresi, G., Aldini, N.N., Torricelli, P., Morrone, G., Guzzardella, G.A., Giardino, R., Krajewski, A., Ravaglioli, A., Belmonte, M.M., Benedittis, A.D., and Biagini, G. (2000) The effect of osteopenia on the osteointegration of different biomaterials: histomorphometric study in rats.
J. Mater. Sci.: Mater. Med.
,
11
(9), 579–585.
Fresenius, R. (1867) Über die Bestimmung der Phosphorsäure im Phosphorit nebst Mittheilung der Analysen des Phosphorits und Staffelits aus dem Lahnthal.
Z. Analyt. Chem.
,
6
, 403–409.
Garvie, R.C. (1978) Stabilization of the tetragonal structure in zirconia microcrystals.
J. Phys. Chem.
,
82
(2), 218–224.
Garvie, R.C., Hannink, R.H.J., and Pascoe, R.T. (1975) Ceramic steel?
Nature
,
258
, 703–704.
Garvie, R.C. and Nicholson, P.S. (1972) Structure and thermodynamical properties of partially stabilized zirconia in the CaO-ZrO
2
system.
J. Am. Ceram. Soc.
,
55
, 152–157.
Garvie, R.C., Urbani, C., Kennedy, D.R., and McNeuer, J.C. (1984) Biocompatibility of Mg-PSZ ceramics.
J. Mater. Sci.
,
19
(10), 3224–3228.
Glien, W., Kerbe, F., and Langer, G. (1976) Keramik in der Chirurgie.
Hermsdorfer Techn. Mitt.
,
16
, 445.
Good, J.M., Olinthus, G., and Newton, B. (1813)
Pantologia: A New Cyclopædia, Comprehending a Complete Series of Essays, Treatises, and Systems, Alphabetically Arranged; with a General Dictionary of Arts, Sciences, and Words: the Whole Presenting a Distinct Survey of Human Genius, Learning, and Industry
, vol. IX. P – PYX, G. Kearsley, London.
Gorelick, L. and Gwinnett, A.J. (1987) A history of drills and drilling.
NY State Dent. J.
,
53
(1), 35–39.
Griss, P. (1984) in
Fundamental Behaviour of Orthopedic Biomaterials
, Vol. II: Applications, CRC Series in Structure-Property Relationships of Biomaterials (eds P. Ducheyne and G.W. Hastings), CRC Press, Boca Raton, FL, pp. 22–43.
Griss, P., von Adrian-Werburg, H., Krempien, B., and Heimke, G. (1973) Biological activity and histocompatibility of dense Al
2
O
3
/MgO ceramic implants in rats.
J. Biomed. Mater. Res.
,
7
(3), 453–462.
Griss, P. and Heimke, G. (1981) in
Biocompatibility of Clinical Implant Materials
, CRC Series in Biocompatibility, vol. 1 (eds D.F. Williams
et al
.), CRC Press, Boca Raton, FL, pp. 156–198.
Gruner, H. (1986) Coating of an implant body. Intern. Patent Appl. WO 1986/006617 A1.
Hayashi, K., Matsuguchi, N., Uenoyama, K., and Sugioka, Y. (1992) Re-evaluation of the biocompatibility of bioinert ceramics in vivo.
Biomaterialia
,
13
(4), 195–200.
Heilmeyer, W.-D. (1981) Antike Werkstattfunde in Griechenland.
Archäolog. Anzeiger
, 440–453.
Heimann, R.B. (2010)
Classic and Advanced Ceramics. From Fundamentals to Applications
, Wiley-VCH Verlag GmbH, Weinheim. ISBN: 978-3-527-32517-7.
Heimann, R.B. (2012) in
Calcium Phosphate. Structure, Synthesis, Properties, and Applications
, Biochemistry Research Trends Series (ed. R.B. Heimann), Nova Science Publishers, New York, pp. 467–473.
Heimann, R.B. and Maggetti, M. (2014)
Ancient Ceramics. Materials, Technology, Art, and Culinary Traditions
, Chapter 16, Schweizerbart Science Publishers, Stuttgart.
Helmer, J.D. and Driskell, T.D. (1969) Research on bioceramics. Symposium on Use of Ceramics as Surgical Implants, Clemson University, Clemson, SC.
Hendricks, S.B., Hill, W.A., Jakobs, K.D., and Jefferson, M.E. (1931) Structural characteristics of apatite-like substances and composition of phosphate rock and bone as determined from microscopical and X-ray examinations.
Ind. Eng. Chem.
,
23
(12), 1413–1418.
Heughebaert, J.C. and Bonel, G. (1986) in
Biological and Biomechanical Performance of Biomaterials
(eds P. Christel, A. Meunier, and A.J.C. Lee), Elsevier, Amsterdam, pp. 9–14.
Hulbert, S.F., Morrison, S.J., and Klawitter, J.J. (1972) Tissue reaction to three ceramics of porous and non-porous structures.
J. Biomed. Mater. Res.
,
6
(5), 347–374.
Hulbert, S.F., Young, F.A., Matthews, R.S., Klawitter, J.J., Talbert, C.D., and Stelling, F.H. (1970) Potential of ceramic materials as permanently implantable skeletal prostheses.
J. Biomed. Mater. Res.
,
4
(3), 433–456.
Jarcho, M. (1981) Calcium phosphate ceramics as hard tissue prosthetics.
Clin. Orthop. Relat. Res.
,
157
, 259–278.
Jarcho, M., Bolen, C.H., Thomas, M.B., Bobick, J., Kay, J.F., and Doremus, R.H. (1976) Hydroxylapatite synthesis and characterization in dense polycrystalline form.
J. Mater. Sci.
,
11
, 2027–2035.
Klement, R. and Trömel, G. (1932) Hydroxylapatit, der Hauptbestandteil der anorganischen Knochen- und Zahnsubstanz Hoppe-Seyler's.
Z. Physiol. Chem.
,
213
, 263–269.
León, B. and Jansen, J.A. (2009)
Thin Calcium Phosphate Coatings for Medical Implants
, Springer, New York. ISBN: 978-0-387-77718-4.
Manicone, P.F., Rossi Iommetti, P., and Raffaeli, L. (2007) An overview of zirconia ceramics: properties and clinical applications.
J. Dent.
,
35
(11), 819–826.
Marggraf, A.S. (1754) De l'alun. Memor. Acad. Sci. Berlin,
X
, 31-51.
Marggraf, A.S. (1761) Versuche mit der Alaun-Erde.
Chym. Schriften, 1. Theil, Kap.
,
12
, 212 ff.
Mitscherlich, E. (1844)
Lehrbuch der Chemie
, Band 1: Die Metalloide, 4th edn, Berlin E.S.Mittler.
Mittelmeier, H., Heisel, J., and Schmitt, E. (1987)
Primär- und Revisions-Alloarthroplastik Hüft- und Kniegelenke
, Springer, Berlin, Heidelberg, pp. 103–116.
Morey, G.W. (1938)
Properties of Glass
, ACS Monograph Series, vol. 77, Reinhold Publishing Corporation, New York.
Nkamgueu, E.M., Adnet, J.J., Bernard, J., Zierold, K., Kilian, L., Jallot, E., Benhayoune, H., and Bonhomme, P. (2000)
In vitro
effects of zirconia and alumina particles on human blood monocyte–derived macrophages: X-ray microanalysis and flow cytometric studies.
J. Biomed. Mater. Res.
,
52
(4), 587–594.
Parr, B. (1809)
The London Medical Dictionary
, vol. 1, J. Johnson, London.
Pasteris, J.D. (2012) in
Calcium Phosphate. Structure, Synthesis, Properties, and Applications
, Biochemistry Research Trends Series (ed. R.B. Heimann), Nova Science Publishers, New York, pp. 63–94.
Pemberton, C.R. (1814)
A Practical Treatise on Various Diseases of the Abdominal Viscera
, 3rd edn, revised and corrected, Bulmer and Company, London.
Piconi, C. and Maccauro, G. (1999) Zirconia as biomaterial.
Biomaterialia
,
20
(1), 1–25.
Piconi, C., Maccauro, G., Muratori, F., and Brach del Prever, E. (2003) Alumina and zirconia ceramics in joint replacement.
J. Appl. Biomater. Biomech.
,
1
(1), 19–32.
Rey, C., Combes, C., Drouet, C., and Glimcher, M.J. (2010) Bone mineral: update on chemical composition and structure.
Osteoporosis Int.
,
20
(6), 1013–1021.
Rieger, W. (2001) in
World Tribology Forum in Arthroplasty
(eds C. Rieker, S. Oberholzer, and U. Wyss), Hans Huber, Bern, pp. 309–318.
Rock, M. (1933) Künstliche Ersatzteile für das Innere und Äussere des menschlichen und tierischen Körpers. Deutsches Reichspatent DRP 583 589, 24 August 1933.
Röntgen, W.C. (1895) Über eine neue Art von Strahlen (Vorläufige Mittheilung).
Sitzungsber. Würzb. Phys. Med. Ges.
,
137
, 132–141.
Roseberry, H.H., Hastings, A.B., and Morse, J.K. (1931) X-ray analysis of bone and teeth.
J. Biol. Chem.
,
90
, 395–407.
Rühle, M., Claussen, N., and Heuer, A.H. (1983)
Science and Technology of Zirconia II
, Advances in Ceramics, vol. 12, American Ceramic Society, 842 pp. ISBN: 978-0-9160-9464-5.